*|MC:SUBJECT|*
BioRN News November 2021
View this email in your browser

Dear *|FNAME|* *|LNAME|*,


to warm up the winter-cold evenings ahead of us, have a look to our contribution to "Starkes Land Baden-Württemberg" as special issue of DER SPIEGEL, published on November 20 - HOT FROM THE PRESS!

A beautiful roundup about BioLabs Heidelberg recently appeared on the start-up portal EU-Startup. Looking forward to attract international start-ups as well as local ones originating from the Heidelberg’s renowned academic institutions.
A new BioLabs sponsor has been announced yesterday: Sanofi is also renewing its commitment to the region and BioLabs model!
...and BioLabs Heidelberg is hiring. Great positions and opportunities!

I am also renewing the invitation to BioRN Network Members’ Assembly on December 9th at 5 pm. The event is virtual, but BioRN achievements this year are really tangible! See you there.

Last, we are really looking forward to address an essential topic in a BioRN Espresso series: "SAMPLES and DATA to improve healthcare: Value - Potential - Challenges": "SAMPLES and DATA to improve healthcare: Value - Potential - Challenges". Join us in our first meeting on February 1, 2022 at 11 am!

Enjoy the read!
 
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New BioRN Members
03 | BioRN Espresso series from February 2022
04 | Funding - Research Grants
05 | Event Calendar & Discounts
06 | Open Positions
01| Research Highlights & News

BioRN:
  • Strengthening the Heidelberg-Mainz Axis towards faster biomedical innovation [more]
  • Der Gesundheit einen Schritt voraus – 25 Jahre BioRN [more]
  • Sanofi unterstützt BioLabs-Inkubator in Heidelberg [more]
Affimed Announces New Innate Cell Engager AFM28 Targeting CD123 to Treat Acute Myeloid Leukemia [more]

BioMed X Insitute successfully completes fourth project in oncology in collaboration with Merck [more]

DKFZ:
  • Tumor organoids can help overcome therapy resistance of colorectal cancer [more]
  • Using T cells to target malignant brain tumors [more]
EMBL:
  • Structure of a promiscuous protein will help scientists design better drugs [more]
  • Celebrating Lithuania-EMBL cooperation on life science research [more]
KIT: How Cells Correctly Choose Active Genes [more]

Owkin becomes ’unicorn’ with $180m investment from Sanofi and four new collaborative projects [more]

 

02 | New BioRN Members

10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We build products to interrogate biological systems at a resolution and scale that matches the complexity of biology. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you resolve highly intricate biological systems, while bringing into focus the details that matter most. [more]

LBBW Venture Capital GmbH invests in innovative technology-driven companies in the fields of life sciences, digital transformation and fintech in the DACH region since 1998. In life sciences & healthcare our focus is on drug development, diagnostics, medtech, bioanalytics, and digital health. LBBW VC financially supports companies during their growth stage with initial tickets from 0,5M€ to 3M€ and has sufficient capital for follow-on rounds. [more]

03 | BioRN Espresso series from February 2022


SAMPLES and DATA to improve healthcare: Value - Potential - Challenges

On February 1 at 11 am
"Access to patient data and samples: Different perspectives and main issues"
 

with Peter Schirmacher - Director of the Institute of Pathology - Heidelberg University Hospital
Andreas Schmidt - CEO - Proteona
Philipp Mann - Senior Partnership Manager - Owkin


This is a digital event

Register here!

04 | Funding - Research Grants


BMBF - Modeling the spread of infectious diseases [more]
BMBF - Multidisciplinary projects for personalized medicine [more]
BMBF - New products for bioeconomy [more]
BMBF - Eurostars 3 funding for innovative SMEs [more]
European Innovation Council EIC launched:
Horizon Europe 2021-22 Overview [more]
Invest BW Innovations- und Technologievorhaben [more]
Merck research challenges [more]

 

05 | Event Calendar & Discounts


Biotechgate Digital Partnering
29 Nov - 3 December 2021 digital
Upgrade to premium for free for BioRN members >>

 

EIT Health Catapult Semifinals
December 1-3, 2021 - digital >>
 

5. MDR-Forum "Countdown IVDR und Praxischeck MDR"
December 2, 2021 - digital >>

Evotec Innovation Week
December 6-10, 2021 - digital >>
 


Molecular Modelling with Schrödinger Workshop
December 6-7, 2021 - digital >>
 
Onlinetraining EU-Förderung für KMU: Erste Schritte zum Antrag im EIC Accelerator
December 6, 2021 - digital >>
 

hei_INNOVATION Talks: Innovation Scouting
December 6, 2021 - digital >>
 

Biofit 2021
December 7-9, 2021 digital
10% discount for BioRN members >>

 
Venture Capital Meet & Greet: High-Tech Gründerfonds
December 8, 2021 - digital >>
 

Genesis 2021
December 9, 2021, London & online
10% discount for BioRN members >>

 
GDPR SUMMIT 2021
December 9, 2021, Belgian Cartoons Center of Brussels, Belgium
On-site Ticket for 121 instead of 150 Euro
Online Ticket for 71 instead of 100 Euro
  >>
 

hei_INNOVATION Talks: Startup Ecosystem
December 13, 2021 - digital >>
 
Webseminar: EU-Fördermöglichkeiten für KMU im EU-Forschungsprogramm Horizont Europa
December 16, 2021 - digital >>
 

BIO-Europe Spring
March 28-30 2022, Basel, Switzerland
April 4-6: Digital Partnering Event
12% discount for BioRN members >>

 

06 | Open Positions


BioMed X: BioLabs Heidelberg:
  • Site Director in Heidelberg [more]
  • Administrative and Operations Associate in Heidelberg [more]
  • Lab Technician in Heidelberg [more]
European Vaccine Initiative: Clinical Project Manager (Full Time, Germany) [more]

Heidelberg Pharma: Projektmanager Supply Chain (m/w/d) im Bereich CMC (Chemistry, Manufacturing and Controls) [more]

HITS: Medical Data Specialist, Medical Informatics Scientist or Bioinformatician (m/f/d) in Heidelberg [more]
 
Tweet
Forward
Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Dr. Annalisa Zuccotti

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*